Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday following insider selling activity. The stock traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares changed hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. The stock had previously […]
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday after an insider sold shares in the company. The company traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares traded hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. […]
Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down to $15.52 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) had its target price upped by Needham & Company LLC from $15.00 to $17.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Several other brokerages have also recently issued reports on RXRX. TD Cowen initiated coverage on Recursion Pharmaceuticals […]
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.